Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MP vs MRNA✓SelectedUSD · MRNAMP vs MRNA performance historyLatest closeAs of-3.41%11/17
Stock and ETF performance explorer

MP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+115.5%
MRNA return
+168.0%
Excess return
-52.6%
Maximum drawdown
-65.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.4%-3.9%+0.5%-3.1%
7D-4.4%-17.6%+13.2%-3.1%
30D-13.2%-5.1%-8.1%-13.1%
3M-40.4%+220.8%-261.2%-47.6%
6M-43.1%+321.7%-364.8%-53.6%
YTD-31.0%+601.3%-632.3%-50.7%
1Y-38.8%+735.2%-774.0%-58.2%
3Y+115.5%+170.5%-55.1%+47.0%
All+115.5%+168.0%-52.6%+47.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling